Tissue plasminogen activator, which is used to treat blood clots, may help severely ill patients with COVID-19 who are in respiratory failure, according to a new paper.
Due to the increased need for albuterol inhalers in hospitals for COVID-19, shortages have been occurring in some areas of the country and will likely continue to affect supplies.
Relieving symptoms and optimizing therapies for allergic rhinitis
Nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) has been approved for the treatment of chronic fibrosing interstitial lung disease with a progressive phenotype.
Solid recommendations can require detective work.
The FDA is requesting that manufacturers of bacitracin for injection voluntarily withdraw their product.
Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.
The 2019 Novel Coronavirus outbreak in Wuhan City, China has caused concern as 2 cases have been recently reported in the United States.
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
A new study of a vaccine used against a pneumonia-causing bacteria found that cases of severe pneumonia decreased by 35% among those children who had received the vaccine.